ProQR Therapeutics (PRQR) Long-Term Investments (2019 - 2023)

ProQR Therapeutics (PRQR) has reported Long-Term Investments for 5 consecutive years, with $706669.6 the latest figure, recorded in Q2 2023.

• Quarterly Long-Term Investments changed 0.0% year-over-year to $706669.6 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $706669.6 (changed 0.0% YoY) and the FY2022 annual result came in at $706669.6, up 7662.5% from the prior year.
• Long-Term Investments held at $706669.6 in Q2 2023 per PRQR's latest filing, from $706669.6 in the prior quarter.
• Over the last five years, Long-Term Investments for PRQR reached as high as $794292.1 in Q2 2019 and fell as low as $706.67 in Q1 2021.
• A 5-year average of $501143.1 and a median of $706669.6 in 2021 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2021 — Long-Term Investments plunged 99.79% — and 2022, when it jumped 99900.0%.
• Year by year, Long-Term Investments stood at $488182.4 in 2019, then plunged by 75.06% to $121761.1 in 2020, then plunged by 92.52% to $9103.6 in 2021, then soared by 7662.5% to $706669.6 in 2022, then changed by 0.0% to $706669.6 in 2023.
• According to Business Quant data, Long-Term Investments over the past three periods registered $706669.6, $706669.6, and $706669.6 for Q2 2023, Q1 2023, and Q4 2022 respectively.